ID: ALA3927354

Max Phase: Preclinical

Molecular Formula: C18H11NO5

Molecular Weight: 321.29

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(/C=C/c1ccc([N+](=O)[O-])cc1)c1cc2ccccc2oc1=O

Standard InChI:  InChI=1S/C18H11NO5/c20-16(10-7-12-5-8-14(9-6-12)19(22)23)15-11-13-3-1-2-4-17(13)24-18(15)21/h1-11H/b10-7+

Standard InChI Key:  QFXNRCNXTVYFLC-JXMROGBWSA-N

Associated Targets(non-human)

Protein-glutamine gamma-glutamyltransferase 2 55 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 321.29Molecular Weight (Monoisotopic): 321.0637AlogP: 3.60#Rotatable Bonds: 4
Polar Surface Area: 90.42Molecular Species: HBA: 5HBD: 0
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 4.00CX LogD: 4.00
Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.24Np Likeness Score: -0.49

References

1.  (2015)  Cinnamoyl inhibitors of transglutaminase, 

Source

Source(1):